Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
The Lancet. Infectious Diseases|November 8, 2017
Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectivesLaurent Abel, Jacques Fellay, David W Haas, et al.Journal of Neurovirology|February 21, 2014
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384Paul D Leger, Daniel H Johnson, Gregory K Robbins, et al.Journal for Immunotherapy of Cancer|July 6, 2021
Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancerDiana V Maslov, Karine Tawagi, Madhav Kc, et al.Open Forum Infectious Diseases|April 18, 2015
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group ProtocolsCarrie B Moore, Anurag Verma, Sarah Pendergrass, et al.Journal for Immunotherapy of Cancer|April 18, 2019
Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literatureNoha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, et al.Journal for Immunotherapy of Cancer|June 26, 2019
Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literatureNoha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, et al.Journal for Immunotherapy of Cancer|November 23, 2019
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literatureHoussein Safa, Daniel H Johnson, Van Anh Trinh, et al.Journal for Immunotherapy of Cancer|April 19, 2019
Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitisDaniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.Journal for Immunotherapy of Cancer|October 12, 2018
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitisDaniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.Cancer Discovery|March 12, 2021
Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory MelanomaCara Haymaker, Daniel H Johnson, Ravi Murthy, et al.Pageof 3